Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2010
06/01/2010US7727745 Using uracil-containing oligonucleotide template to generate preferential DNA sequences
06/01/2010US7727742 Nucleic acid molecules encoding fibroblast growth factor-like polypeptides
06/01/2010US7727741 Nucleotide sequences coding glycoengineered peptides with enhance Fc receptor binding affinity and effector function for treatment and prevention of cell proliferative disorders
06/01/2010US7727738 Methods for generating analogs of coenzyme A
06/01/2010US7727723 Droplet-based pyrosequencing
06/01/2010US7727720 Determining sequence of alleles at locus; quantitating ratio for preferential alleles; screen for allelic variants; corellate allelic variant with presence or absence of a chromosomal abnormality
06/01/2010US7727718 Reagents for storage and preparation of samples for DNA analysis
06/01/2010US7727716 Detection of immobilized nucleic acid
06/01/2010US7727715 Using sequestosome 1 as biomarker in diagnosis of cell proliferative disorders of lungs
06/01/2010US7727714 Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma
06/01/2010US7727713 Templated molecules and methods for using such molecules
06/01/2010US7727572 food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010CA2393476C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
06/01/2010CA2203933C Nucleotide sequences hybridizing specifically with a genomic nucleic sequence of campylobacter
05/2010
05/27/2010WO2010060035A1 Snake factor v and methods of use as a procoagulant
05/27/2010WO2010059944A1 A split dna enzyme for visual single nucleotide polymorphism typing
05/27/2010WO2010059323A2 Sequence amplification with target primers
05/27/2010WO2010059206A2 Modular nucleotide compositions and uses therefor
05/27/2010WO2010033753A3 Mutant delta5 desaturases and their use in making polyunsaturated fatty acids
05/27/2010WO2010022166A3 Micro rna and neurofibromatosis type 1 in diagnosis and therapy
05/27/2010WO2010006312A3 Methods and compositions for producing carbon-based products in microorganisms
05/27/2010WO2010002862A3 Fibroblast growth factor receptor 3 (fgfr3) binding proteins
05/27/2010WO2009154804A3 Twin fluorophore peptide nucleic acid hybridization probes
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132074 Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield
05/27/2010US20100132070 Plant Defense Genes and Proteins and Methods of Use
05/27/2010US20100132069 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants
05/27/2010US20100132062 Rice Mutant Allele
05/27/2010US20100132060 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof
05/27/2010US20100132059 Temperature-induced polynucleotides and uses therefor
05/27/2010US20100132056 Germ Cell Marker Using Fish Vasa Gene
05/27/2010US20100131432 Methods and compositions of molecular profiling for disease diagnostics
05/27/2010US20100130733 Luminescent metal ion complexes
05/27/2010US20100130732 System and method for processing target material
05/27/2010US20100130720 Artificial binding proteins based on a modified alpha helical region of ubiquitin
05/27/2010US20100130595 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
05/27/2010US20100130592 RNA Interference Mediated Inhibition of GRB2 Associated Binding Protein (GAB2) Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/27/2010US20100130591 Multiple exon skipping compositions for dmd
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130589 MODULATION OF eIF4E EXPRESSION
05/27/2010US20100130587 METHODS OF TREATING CANCER USING siRNA MOLECULES DIRECTED AGAINST CD24
05/27/2010US20100130586 Diagnosis and treatment of t-cell acute lymphoblastic leukemia
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130433 Casein-Derived Peptides having Anxiolytic Activity
05/27/2010US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
05/27/2010US20100130424 Crhr2 peptide agonists and uses thereof
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130410 Neural regeneration peptides and methods for their use
05/27/2010US20100130381 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
05/27/2010US20100129914 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME
05/27/2010US20100129913 Polioma vector expressing long double-stranded rnas
05/27/2010US20100129904 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); for treating cancer responsive to interferon alpha therapy
05/27/2010US20100129903 Pitx3 expression promoters
05/27/2010US20100129902 Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129889 Affinity separation methods and systems
05/27/2010US20100129879 Genome partitioning using a nicking endonuclease
05/27/2010US20100129877 Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129868 Delta 4,5 glycuronidase compositions and methods related thereto
05/27/2010US20100129866 Method for production of dipeptide
05/27/2010US20100129863 Optimized core promoters and uses thereof
05/27/2010US20100129842 Isobarically labeled analytes and fragment ions derived therefrom
05/27/2010US20100129823 Methods for identifying subjects susceptible to ataxic neurological disease
05/27/2010US20100129821 Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens
05/27/2010US20100129820 Strongly quenching oligomeric excimer/quencher pairs for detection schemes
05/27/2010US20100129819 Methods and compositions in particle-based detection of target molecules using linking molecules
05/27/2010US20100129816 Microbial Population Analysis
05/27/2010US20100129813 Compositions and methods for detecting food-borne pathogens
05/27/2010US20100129811 Compositions for use in identification of pseudomonas aeruginosa
05/27/2010US20100129807 Stabilization of cyclic peptide structures
05/27/2010US20100129800 Polymers and their use as fluorescent labels
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129429 Inhibition of autophagy genes in cancer chemotherapy
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129391 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
05/27/2010US20100129360 Antibodies against human interleukin-13 and uses therefor
05/27/2010US20100129346 Anti-C5aR Antibodies With Improved Properties
05/27/2010US20100129342 Human Growth and Differentiation Factor GDF-5
05/27/2010US20100129325 Seneca valley virus based compositions and methods for treating disease
05/27/2010US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses
05/27/2010US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same
05/27/2010CA2744174A1 Snake factor v and methods of use as a procoagulant
05/26/2010EP2189523A1 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
05/26/2010EP2189469A2 Multicistronic siRNA constructs to inhibit tumors
05/26/2010EP2189468A1 Method for modification of nucleotides in nucleic acid, and nucleic acid having modified nucleotide therein
05/26/2010EP2188298A2 Tetrahydropyran nucleic acid analogs
05/26/2010EP1660650B1 Improved sso7-polymerase conjugate proteins
05/26/2010EP1613345B1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
05/26/2010EP1438321B1 Modified l-nucleic acid
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 899